A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

NCT ID: NCT05398445

Last Updated: 2025-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

769 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-31

Study Completion Date

2025-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A

Rocatinlimab Dose 1 every 4 weeks (Q4W) + loading dose at Week 2

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

Participants will receive Rocatinlimab subcutaneously.

Arm B

Rocatinlimab Dose 2 Q4W + loading dose at Week 2

Group Type EXPERIMENTAL

Rocatinlimab

Intervention Type DRUG

Participants will receive Rocatinlimab subcutaneously.

Arm C

Placebo Q4W+ loading dose at Week 2

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Participants will receive a placebo subcutaneously.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rocatinlimab

Participants will receive Rocatinlimab subcutaneously.

Intervention Type DRUG

Placebo

Participants will receive a placebo subcutaneously.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AMG 451

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years with a diagnosis of AD according to the AAD Consensus Criteria (2014) present for at least 12 months
* History of inadequate response to TCS (Topical Corticosteroid) of medium to higher potency (with or without topical calcineurin inhibitors \[TCI\]).
* EASI score ≥16
* vIGA-AD score ≥3
* ≥10% body surface area (BSA) of AD involvement
* Worst pruritus numerical rating scale ≥ 4

Exclusion Criteria

* Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1
* Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:

* Systemic corticosteroids
* Systemic immunosuppressants
* Phototherapy
* Janus kinase inhibitors
* Treatment with any of the following medications or therapies within 1 week, prior to Day 1:

* TCS of any potency
* TCI
* Topical phosphodiesterase type 4 inhibitors
* Other topical immunosuppressive agents
* Combination topical agents including TCS of any potency, TCI, PDE4 inhibitors, or other topical immunosuppressive agents
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cahaba Dermatology and Skin Health Center

Birmingham, Alabama, United States

Site Status

Alliance Dermatology and Mohs Center

Phoenix, Arizona, United States

Site Status

Anaheim Clinical Trials

Anaheim, California, United States

Site Status

First OC Dermatology

Fountain Valley, California, United States

Site Status

Kaiser Permanente - Glendale Medical Center

Glendale, California, United States

Site Status

Long Beach Research Institute

Long Beach, California, United States

Site Status

Kaiser Permanente Los Angeles Medical Center

Los Angeles, California, United States

Site Status

Dermatology Research Associates

Los Angeles, California, United States

Site Status

Cura Clinical Research

Sherman Oaks, California, United States

Site Status

IMMUNOe Research Centers

Centennial, Colorado, United States

Site Status

Skin Care Research Incorporated

Boca Raton, Florida, United States

Site Status

Palm Beach Dermatology Group

Delray Beach, Florida, United States

Site Status

Global Research Associates

Homestead, Florida, United States

Site Status

Healthy Life Research

Miami, Florida, United States

Site Status

Savin Medical Group LLC

Miami Lakes, Florida, United States

Site Status

Kirsch Dermatology LLC

Naples, Florida, United States

Site Status

Pure Skin Dermatology and Aesthetics

Orlando, Florida, United States

Site Status

Industrial Medicine Associates Ima Clinical Research Inc

St. Petersburg, Florida, United States

Site Status

Genesis Clinical Research LLC

Tampa, Florida, United States

Site Status

Treasure Valley Medical Research

Boise, Idaho, United States

Site Status

DeNova Research

Chicago, Illinois, United States

Site Status

Dundee Dermatology

West Dundee, Illinois, United States

Site Status

The Indiana Clinical Trials Center PC

Plainfield, Indiana, United States

Site Status

Institute for Asthma and Allergy

Chevy Chase, Maryland, United States

Site Status

Continental Clinical Solutions, LLC

Towson, Maryland, United States

Site Status

Henry Ford Health System

Detroit, Michigan, United States

Site Status

Onyx Clinical Research

Flint, Michigan, United States

Site Status

Dermatology and Skin Cancer Center of Lees Summit

Lee's Summit, Missouri, United States

Site Status

Jubilee Clinical Research Inc

Las Vegas, Nevada, United States

Site Status

Allcutis Research, Llc - Portsmouth

Portsmouth, New Hampshire, United States

Site Status

Continental Clinical Solutions - Cherry Hill

Cherry Hill, New Jersey, United States

Site Status

Industrial Medicine Associates Ima Clinical Research Inc

Hartsdale, New York, United States

Site Status

Sadick Research Group

New York, New York, United States

Site Status

Dermatology Specialists of Charlotte

Charlotte, North Carolina, United States

Site Status

Onsite Clinical Solutions

Charlotte, North Carolina, United States

Site Status

Wilmington Dermatology Center

Wilmington, North Carolina, United States

Site Status

The Skin Surgery Center for Clinical Research

Winston-Salem, North Carolina, United States

Site Status

Optima Research

Boardman, Ohio, United States

Site Status

ClinOhio Research Services

Columbus, Ohio, United States

Site Status

Unity Clinical Research

Oklahoma City, Oklahoma, United States

Site Status

Dermatology Research Center of Oklahoma, PLLC

Tulsa, Oklahoma, United States

Site Status

Essential Medical Research LLC

Tulsa, Oklahoma, United States

Site Status

Oregon Health and Science University

Portland, Oregon, United States

Site Status

DermDox Dermatology, LLC

Sugarloaf, Pennsylvania, United States

Site Status

Cumberland Skin Center

Hermitage, Tennessee, United States

Site Status

Dermatology Treatment and Research Center PA

Dallas, Texas, United States

Site Status

The Woodlands Dermatology Associates

The Woodlands, Texas, United States

Site Status

Education and Research Foundation Inc

Lynchburg, Virginia, United States

Site Status

Frontier Derm Partners

Mill Creek, Washington, United States

Site Status

West Virginia Research Institute

Morgantown, West Virginia, United States

Site Status

Cinme - Centro de Investigaciones Metabolicas

CABA, Buenos Aires, Argentina

Site Status

Fundacion Respirar

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status

Hospital Universitario Austral

Derqui, Pilar, Buenos Aires, Argentina

Site Status

Centro Dermatológico Schejtman

San Miguel, Buenos Aires, Argentina

Site Status

InAER - Investigaciones en Alergia y Enfermedades Respiratorias

Buenos Aires, Distrito Federal, Argentina

Site Status

Instituto de Neumonologia y Dermatologia

Buenos Aires, Distrito Federal, Argentina

Site Status

Conexa Investigacion Clinica SA

CABA, Distrito Federal, Argentina

Site Status

Fundacion Estudios Clinicos

Rosario, Santa Fe Province, Argentina

Site Status

Instituto de Diagnostico Abc American British Cowdray

Rosario, Santa Fe Province, Argentina

Site Status

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Ernesto Dornelles

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Upeclin-Pesq Clin FacMed Botucatu

Botucatu, São Paulo, Brazil

Site Status

Hosp e Maternidade Dr Christovao da Gama

Santo André, São Paulo, Brazil

Site Status

Fundacao Abc - Centro Univ Fmabc

Santo André, São Paulo, Brazil

Site Status

Consultoria Medica e Pesquisa Clinica Cmpc

Sorocaba, São Paulo, Brazil

Site Status

IBPClin Instituto Brasil de Pesquisa Clinica

Rio de Janeiro, , Brazil

Site Status

Alergoalfa Nucleo Diagnostico Tratamento e Pesquisa Clinica em Alergia

São Paulo, , Brazil

Site Status

Alberta Derma Surgery Centre

Edmonton, Alberta, Canada

Site Status

Vida Clinical Research

Edmonton, Alberta, Canada

Site Status

CCA Medical Research Corporation

Ajax, Ontario, Canada

Site Status

SimcoDerm Medical and Surgical Dermatology Centre

Barrie, Ontario, Canada

Site Status

LEADER Research

Hamilton, Ontario, Canada

Site Status

DermEdge Research Incorporated

Mississauga, Ontario, Canada

Site Status

Canadian Dermatology Centre

North York, Ontario, Canada

Site Status

Gordon Sussman Clinical Research Incorporated

North York, Ontario, Canada

Site Status

Oak Ridges Aesthetics Centre

Richmond Hill, Ontario, Canada

Site Status

Innovaderm Research Inc

Montreal, Quebec, Canada

Site Status

Recherche Clinique Sigma Incorporated

Québec, Quebec, Canada

Site Status

Skinsense Medical Research

Saskatoon, Saskatchewan, Canada

Site Status

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status

The First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

Site Status

The First Affiliated Hospital ,Sun-Yat Sen University

Guangzhou, Guangdong, China

Site Status

Dermatology Hospital of Southern Medical University

Guangzhou, Guangdong, China

Site Status

Sun Yat-sen Memorial Hospital Sun Yat-sen University

Guangzhou, Guangdong, China

Site Status

The First Hospital Of Hebei Medical University

Shijiazhuang, Hebei, China

Site Status

Nanyang First Peoples Hospital

Nanyang, Henan, China

Site Status

Sanmenxia Central Hospital

Sanmenxia, Henan, China

Site Status

Union Hospital Tongji Medical College Huazhong University of science and Technology

Wuhan, Hubei, China

Site Status

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China

Site Status

Jiangyin Hospital of Traditional Chinese Medicine

Jiangyin, Jiangsu, China

Site Status

Wuxi Peoples Hospital

Wuxi, Jiangsu, China

Site Status

Dermatology Hospital of Jiangxi Province

Nanchang, Jiangxi, China

Site Status

The First Hospital of Jilin University

Changchun, Jilin, China

Site Status

The First Hospital of China Medical University

Shenyang, Liaoning, China

Site Status

Chengdu Second Peoples Hospital

Chengdu, Sichuan, China

Site Status

the First Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

Zhejiang Provincial Peoples Hospital

Hangzhou, Zhejiang, China

Site Status

Affiliated Hangzhou First Peoples Hospital,Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Site Status

Taizhou Central Hospital

Taizhou, Zhejiang, China

Site Status

Peking University Peoples Hospital

Beijing, , China

Site Status

Shanghai Skin Disease Hospital

Shanghai, , China

Site Status

Special Hospital for Medical Rehabilitation Naftalan

Ivanić-Grad, , Croatia

Site Status

Sestre milosrdnice University Hospital Center

Zagreb, , Croatia

Site Status

University Hospital Centre Zagreb

Zagreb, , Croatia

Site Status

Dermamedica, sro

Náchod, , Czechia

Site Status

CCR Ostrava sro

Ostrava, , Czechia

Site Status

Pratia Pardubice as

Pardubice, , Czechia

Site Status

Clintrial sro

Prague, , Czechia

Site Status

Pratia Prague sro

Prague, , Czechia

Site Status

Fakultni nemocnice Bulovka

Prague, , Czechia

Site Status

Krajska zdravotni as - Masarykova nemocnice Usti nad Labem oz

Ústí nad Labem, , Czechia

Site Status

Charite - Universitaetsmedizin Berlin, Campus Mitte

Berlin, , Germany

Site Status

Dermatologische Gemeinschaftspraxis-Mahlow

Blankenfelde-Mahlow, , Germany

Site Status

Hautarztpraxis Dr Niesmann und Dr Othlinghaus

Bochum, , Germany

Site Status

Rosenpark Research GmbH

Darmstadt, , Germany

Site Status

Universitaetsklinikum Dresden

Dresden, , Germany

Site Status

Heinrich-Heine-Universitaet Duesseldorf - Universitaetsklinikum Duesseldorf

Düsseldorf, , Germany

Site Status

Universitaetsklinikum Essen

Essen, , Germany

Site Status

Institute for Health Services Research in Dermatology and Nursing

Hamburg, , Germany

Site Status

Universitaetsklinikum Heidelberg

Heidelberg, , Germany

Site Status

Hautarztpraxis Dres Leitz und Kollegen

Stuttgart, , Germany

Site Status

Universitaetsklinikum Tuebingen

Tübingen, , Germany

Site Status

CentroDerm GmbH

Wuppertal, , Germany

Site Status

Athens Naval Hospital

Athens, , Greece

Site Status

Thoracic General Hospital Of Athens Sotiria

Athens, , Greece

Site Status

University General Hospital Attikon

Athens, , Greece

Site Status

Andreas Syngros Hospital Of Venereal And Dermatological Diseases

Athens, , Greece

Site Status

University General Hospital of Ioannina

Ioannina, , Greece

Site Status

General University Hospital of Larissa

Larissa, , Greece

Site Status

Papageorgiou General Hospital

Thessaloniki, , Greece

Site Status

Medmare Bt

Veszprém, , Hungary

Site Status

Universita degli Studi Gabriele D Annunzio di Chieti e Pescara

Chieti, , Italy

Site Status

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

Milan, , Italy

Site Status

Azienda Ospedaliera di Perugia Ospedale Santa Maria della Misericordia

Perugia, , Italy

Site Status

Azienda Ospedaliera Policlinico Umberto I

Roma, , Italy

Site Status

Azienda Ospedaliera Citta della Salute e della Scienza di Torino

Torino, , Italy

Site Status

Aichi Medical University Hospital

Nagakute-shi, Aichi-ken, Japan

Site Status

Japan Community Healthcare Organization Chukyo Hospital

Nagoya, Aichi-ken, Japan

Site Status

Central Clinic

Nagoya, Aichi-ken, Japan

Site Status

Nagoya City University Hospital

Nagoya, Aichi-ken, Japan

Site Status

Fukuoka University Hospital

Fukuoka, Fukuoka, Japan

Site Status

Matsuo Clinic

Fukuoka, Fukuoka, Japan

Site Status

Fukushima Medical University Hospital

Fukushima, Fukushima, Japan

Site Status

Asahikawa City Hospital

Asahikawa-shi, Hokkaido, Japan

Site Status

Tokyo Medical University Ibaraki Medical Center

Inashiki-gun, Ibaraki, Japan

Site Status

Kaji Dermatology Clinic

Nonoichi-shi, Ishikawa-ken, Japan

Site Status

Iwate Medical University Uchimaru Medical Center

Morioka, Iwate, Japan

Site Status

Takeoka Dermatology Clinic

Marugame-shi, Kagawa-ken, Japan

Site Status

Nippon Medical School Musashikosugi Hospital

Kawasaki-shi, Kanagawa, Japan

Site Status

University Hospital Kyoto Prefectural University of Medicine

Kyoto, Kyoto, Japan

Site Status

Rakuwakai Otowa Hospital

Kyoto, Kyoto, Japan

Site Status

Mochida Dermatology Clinic

Izumiotsu-shi, Osaka, Japan

Site Status

Dokkyo Medical University Hospital

Shimotsuga-gun, Tochigi, Japan

Site Status

Teikyo University Hospital

Itabashi-ku, Tokyo, Japan

Site Status

Nihon University Itabashi Hospital

Itabashi-ku, Tokyo, Japan

Site Status

Outpatient clinic Veselibas Centrs 4

Riga, , Latvia

Site Status

Outpatient clinic Veselibascentrs 4

Riga, , Latvia

Site Status

Smite Aija practice in dermatology and venerology

Talsi, , Latvia

Site Status

PreCare Trial and Recruitment

Born, , Netherlands

Site Status

AKK Medical Spolka z ograniczona odpowiedzialnoscia Centrum Medyczne Tu sie leczy

Gdansk, , Poland

Site Status

Centrum Medyczne Angelius Provita

Katowice, , Poland

Site Status

Centrum Zdrowia i Urody Maxxmed

Lublin, , Poland

Site Status

Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Spzoo

Malbork, , Poland

Site Status

Twoja przychodnia Ncm

Nowa Sól, , Poland

Site Status

Twoja przychodnia Pcm

Poznan, , Poland

Site Status

Twoja Przychodnia Scm

Szczecin, , Poland

Site Status

Alergo-Med Specjalistyczna Przychodnia Lekarska Spzoo

Tarnów, , Poland

Site Status

Royalderm Agnieszka Nawrocka

Warsaw, , Poland

Site Status

Dermatologiczna Praktyka Lekarska Michal Torz Dermaceum Centrum Badan Klinicznych

Wroclaw, , Poland

Site Status

Hospital Lusiadas Lisboa

Lisbon, , Portugal

Site Status

Hospital Cuf Descobertas

Lisbon, , Portugal

Site Status

Unidade Local de Saude de Matosinhos, EPE - Hospital Pedro Hispano

Matosinhos Municipality, , Portugal

Site Status

Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio

Porto, , Portugal

Site Status

Clinical Research of Puerto Rico

San Juan, , Puerto Rico

Site Status

Fakultna Nemocnica s poliklinikou F D Roosevelta Banska Bystrica

Banská Bystrica, , Slovakia

Site Status

Derma therapy, spol s ro

Bratislava, , Slovakia

Site Status

Sanare spol sro

Svidník, , Slovakia

Site Status

Kaderma Majtan, sro

Topoľčany, , Slovakia

Site Status

Fakultna nemocnica Trnava

Trnava, , Slovakia

Site Status

Korea University Ansan Hospital

Ansansi, Gyeonggido, , South Korea

Site Status

The Catholic University of Korea Incheon St Marys Hospital

Incheon, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

National Medical Center

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Korea University Guro Hospital

Seoul, , South Korea

Site Status

Hospital Universitario Reina Sofia

Córdoba, Andalusia, Spain

Site Status

Hospital Universitario Miguel Servet

Zaragoza, Aragon, Spain

Site Status

Hospital Universitario de Gran Canaria Doctor Negrin

Las Palmas de Gran Canaria, Canary Islands, Spain

Site Status

Hospital Universitari Germans Trias i Pujol

Badalona, Catalonia, Spain

Site Status

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Catalonia, Spain

Site Status

Hospital Clinico Universitario de Santiago

Pontevedra, Galicia, Spain

Site Status

Hospital Universitario Quironsalud Madrid

Pozuelo de Alarcón, Madrid, Spain

Site Status

Hospital Universitari i Politecnic La Fe

Valencia, Valencia, Spain

Site Status

Hospital Universitario de La Princesa

Madrid, , Spain

Site Status

Hospital Universitario Infanta Leonor

Madrid, , Spain

Site Status

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Mackay Memorial Hospital Taipei Branch

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Linkou Chang Gung Memorial Hospital

Taoyuan District, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Brazil Canada China Croatia Czechia Germany Greece Hungary Italy Japan Latvia Netherlands Poland Portugal Puerto Rico Slovakia South Korea Spain Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Guttman-Yassky E, Simpson E, Bissonnette R, Eichenfield LF, Kabashima K, Luna PC, Hercogova JT, Spelman L, Worm M, Esfandiari E, Arai T, Mano H, Charuworn P, Wang A, Kricorian G. ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis. Immunotherapy. 2025 Feb;17(2):83-94. doi: 10.1080/1750743X.2025.2464528. Epub 2025 Feb 26.

Reference Type BACKGROUND
PMID: 40012373 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-501540-15-00

Identifier Type: CTIS

Identifier Source: secondary_id

20210142

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.